Co-Diagnostics
CODX
88 hedge funds and large institutions have $61M invested in Co-Diagnostics in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 32 reducing their positions, and 29 closing their positions.
0.21% less ownership
Funds ownership: 1.05% → 0.84% (-0.21%)
7% less funds holding
Funds holding: 95 → 88 (-7)
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
29% less capital invested
Capital invested by funds: $85.7M → $61M (-$24.7M)
41% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 32
48% less call options, than puts
Call options by funds: $4.14M | Put options by funds: $7.96M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.83M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$3.12M |
| 3 |
E
Ergoteles
New York
|
+$1.17M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$937K |
| 5 |
Morgan Stanley
New York
|
+$827K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$12.3M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$7.55M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.03M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.17M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$2.03M |
CODX Hedge Fund Activity: Q2 2021 in Review
88 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2021, worth a combined $61M — down 29% from $85.7M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CODX and 22 opened new positions — a net loss of 7 holders — while 32 trimmed existing stakes and 19 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $3.83M. The largest seller was BlackRock, cutting an estimated $12.3M.
- 88 institutional investors held Co-Diagnostics (CODX) as of Q2 2021, down from 95 in Q1 2021.
- Funds reported $61M of Co-Diagnostics stock for Q2 2021, down 29% quarter-over-quarter.
- 22 funds opened new Co-Diagnostics positions in Q2 2021 and 29 closed out, a net change of -7 holders.
- The largest Co-Diagnostics buyer in Q2 2021 was Millennium Management, an estimated $3.83M added.
- The largest Co-Diagnostics seller in Q2 2021 was BlackRock, an estimated $12.3M sold.
Based on aggregated 13F filings for Q2 2021.